Ekachai Medical Care Public Company (EKH) Fair Value & Analysis
Healthcare · TH · Market cap 4.0B THB
Fair value as of: Jun 24, 2026
Analysis
Ekachai Medical Care Public Company (EKH) currently trades at 4.96 THB, while our model-based Fair Value estimate is 5.83 THB — implying the stock looks roughly 17.5% undervalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Ekachai Medical Care Public Company Limited, together with its subsidiaries, operates Ekachai hospital in Thailand. The company offers various surgeries comprising face and neck lift; forehead augmentation; eyelid and ear correction; nose reshaping; breast lifting, implants, reduction with implants, and lifting without implants; nipple-areolar; preventive mastectomy; male breast reduction; mastectomy; power assisted and body tite liposuction; lipofilling; body contouring; female genetical cosmetic; and gender reassugnment. It also operates cosmetic surgery; EKI-IVF Fertility and genetic; ophthalmology; obstertrics and gynaecology; pediatrics; orthopedics; general surgery; emergency; health promotion; hemodialysis; dental; physical; pre employment and mobile checkup; internal medicine; aesthetic and dermatology; and child and teen development centers. In addition, the company provides infertility and elderly care centers; and operates psychiatric hospitals, and specialized hospitals …
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Ekachai Medical Care Public Company (EKH) undervalued?
What is the fair value of EKH?
What is the quality score of EKH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.